Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Biofrontera Inc. (BFRI) had Revenue of $37.32M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$37.32M
Net Income	$-17.76M
Cost of Goods Sold	$18.61M
Gross Profit	$18.71M
Operating Expenses	$54.53M
Operating Income	$-17.21M
Non-Operating Income/Expense	$-0.53M
Pre-Tax Income	$-17.74M
Normalized Pre-Tax Income	$-17.74M
Income after Taxes	$-17.76M
Income from Continuous Operations	$-17.76M
Consolidated Net Income/Loss	$-17.76M
Normalized Income after Taxes	$-17.76M
EBIT	$-17.21M
EBITDA	$-16.06M
Weighted-Average Shares Outstanding (Basic)	5.52M
Weighted-Average Shares Outstanding (Diluted)	5.52M
Earnings per Share (EPS) (Basic)	$-3.22
Earnings per Share (EPS) (Diluted)	$-3.22
Balance Sheet Financials
Current Assets	$20.70M
Property, Plant, and Equipment	$0.08M
Long-Term Assets	$1.40M
Total Assets	$22.10M
Current Liabilities	$12.02M
Long-Term Debt	$4.10M
Long-Term Liabilities	$5.65M
Total Liabilities	$17.67M
Common Equity	$4.43M
Tangible Shareholders Equity	$4.40M
Shareholders Equity	$4.43M
Common Shares Outstanding	8.87M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-10.27M
Cash Flow from Investing Activities	$-0.00M
Cash Flow from Financial Activities	$14.84M
Beginning Cash	$1.54M
End Cash	$6.11M
Increase/Decrease in Cash	$4.56M
Stock-Based Compensation	$1.02M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.72
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.48
Debt to Equity Ratio	0.92
Gross Margin	50.14%
Operating Margin	-46.11%
EBIT Margin	-46.11%
EBITDA Margin	-43.03%
Pre-Tax Profit Margin	-47.53%
Profit Margin	-47.58%
Free Cash Flow	$-10.28M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.69
Inventory Turnover	2.80
Receiveable Turnover	7.02
Days Sales in Receivables	51.98
Return on Equity	-400.61%
Return on Tangible Equity	-403.80%
Return on Assets	-80.35%
Return on Investments	-208.17%
Book Value Per Share	$0.50
Free Cash Flow per Share	$-1.86
Operating Cash Flow per Share	$-1.86

Data from Zacks Investment Research, Inc.